Gastroenterology Abstracts On The Go

This research investigates how tracking the concentration and processing speed of infliximab can determine the success of emergency treatment for acute severe ulcerative colitis. By analyzing blood and stool samples, the study discovered that low drug levels and rapid clearance shortly after the first dose are strong predictors of treatment failure and the future need for surgery. The findings sug...

This prospective study utilizes real-time electronic health data to confirm that newly diagnosed diabetes in older adults serves as a significant early warning sign for pancreatic cancer. By tracking patients over a three-year period, researchers discovered that while the overall risk is high, there are pronounced racial and ethnic disparities, with non-Hispanic White patients showing the highest...

Researchers have developed a promising new strategy to combat pancreatic cancer by using a specialized inhibitor called BB2–30F to block the uPA enzyme system, which typically drives tumor spread. By combining this inhibitor with traditional chemotherapy, the study demonstrated a significant ability to stunt primary tumor growth and, remarkably, eliminate visible distant metastasis in animal model...

Recent financial data reveals a significant shift in the pharmaceutical landscape as the drug Skyrizi has officially surpassed Humira in global sales, marking a pivotal transition for the manufacturer AbbVie. This change is driven by a strategy known as product hopping, where companies encourage patients to move from older medications facing generic competition to newer, patented treatments. While...

The year 2025 marks a transformative shift in the pharmaceutical landscape as multiple low-cost biosimilars enter the U.S. market to compete with the high-revenue drug Stelara. Following a series of legal delays and patent settlements, several pharmaceutical companies have launched alternative treatments for chronic inflammatory conditions, such as Crohn’s disease and plaque psoriasis. These new o...

This text details the arrival of Wezlana, the first interchangeable biosimilarto the blockbuster drug Stelara, marking a shift toward more affordable treatment options for autoimmune and gastrointestinal diseases. By securing an interchangeability status, this new medication can be substituted by pharmacists without a provider's intervention, potentially increasing patient access while address...

This expert review provides a comprehensive framework for the clinical management of nonampullary duodenal polyps, which are often discovered incidentally during routine medical exams. The text outlines essential diagnostic protocols, emphasizing the need to distinguish between benign mimics and true adenomas while carefully mapping a lesion's location relative to the major papilla. Because th...

Gastro Hep Advances  A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease Volume 3, Issue 4P498-5052024  This study explored the use of machine learning (ML) models to predict the risk of hepatocellular carcinoma (HCC) in patients suffering from metabolic dysfunction-associated steatotic liver disease (MASL...

Gastro Hep Advances  The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways Volume 3, Issue 2P167-1772024 This research investigates how the gut's microbial community, or microbiome, differs in individuals with Crohn's disease (CD) who have persistent symptoms despite being in a state of quiescent disease (no inflam...

Gastro Hep Advances  Dynamics of Virological and Clinical Response Parameters of Bulevirtide Treatment for Hepatitis D: Real-World Data Volume 3, Issue 3P353-3602024 This study examines the real-world application of $\mathbf{bulevirtide}$, the first targeted treatment for $\mathbf{Hepatitis\ D\ virus\ (HDV)}$, using data from 15 patients. The research aimed to understand the timeline of patient im...

  FROM Gastro Hep Advances  Esophageal Symptoms and Lumbosacral Back Pain Volume 3, Issue 2P292-2992024 This study investigated a potential link between typical esophageal symptoms—such as heartburn, difficulty swallowing, and chest pain—and chronic lumbosacral back pain. Researchers compared patients referred for esophageal assessment with a control group undergoing routine colonoscopy, using que...

FROM Techniques and Innovations in Gastrointestinal Endoscopy Clinical Efficacy and Safety of a Novel Stent for Fistula Management Following Sleeve Gastrectomy Volume 26, Issue 1P12-202024 This study explores the clinical efficacy and safety of a new stent design for managing fistulas following sleeve gastrectomy (SG), reflecting a broader shift from surgical to primarily endoscopic treatment meth...

Techniques and Innovations in Gastrointestinal Endoscopy Development and Validation of an Automated, Real-time Adenoma Detection Rate and Colonoscopy Quality Metrics Calculator Volume 26, Issue 1P2-112024  This study details the creation of a sophisticated, fully automated platformdesigned to efficiently measure the quality of colonoscopy procedures. Recognizing that a high-quality colonoscopy si...

Techniques and Innovations in Gastrointestinal Endoscopy Magnetic Compression Anastomosis for Esophageal Obstruction: Indications, Contraindications, Methodologies, and Technique Strategies Volume 26, Issue 3P206-2152024 This study evaluates Magnetic Compression Anastomosis (MCA) as a promising and novel technique for treating severe or refractory esophageal obstruction, offering an alternative to...

FROM Techniques and Innovations in Gastrointestinal Endoscopy Randomized Double-blind Sham-controlled Trial of a Novel Silicone-filled Endoscopically Placed Device for Weight Loss Volume 26, Issue 1P21-292024 This research details a randomized, double-blind, sham-controlled trialinvestigating a novel, endoscopically placed intragastric device called the TransPyloric Shuttle for treating Class I an...

FROM Techniques and Innovations in Gastrointestinal Endoscopy Limitations of the Location-Based and Polyp-Based Resect and Discard Strategies Volume 26, Issue 3P237-2432024 This study explored two new approaches, the Location-Based Resect and Discard (LBRD) and Polyp-Based Resect and Discard (PBRD) strategies, aimed at reducing the expense associated with colonoscopy screenings by minimizing the n...

Clinical Gastroenterology and Hepatology  Vedolizumab, Adalimumab, and Methotrexate Combination Therapy in Crohn’s Disease (EXPLORER) Volume 22, Issue 7P1487-1496.E12July 2024 The EXPLORER study investigated whether a triple combination therapy—specifically using vedolizumab, adalimumab, and methotrexate—could improve treatment outcomes for individuals with newly diagnosed, moderate-to-high-risk C...

Clinical Gastroenterology and Hepatology  ​​Coconut Water Induces Clinical Remission in Mild to Moderate Ulcerative Colitis: Double-blind Placebo-controlled Trial This research investigated whether coconut water (CW) could serve as an effective adjunct therapy for individuals with mild to moderate ulcerative colitis (UC), a condition it may help by manipulating the gut microbiome and reducing infl...

 Clinical Gastroenterology and Hepatology  Type 1 Autoimmune Pancreatitis in Europe: Clinical Profile and Response to Treatment Volume 22, Issue 5P994-1004.E10May 2024 This large-scale European study characterized the presentation and treatment effectiveness for Type 1 Autoimmune Pancreatitis (AIP), a condition where the immune system attacks the pancreas. Analyzing data from over 700 adults, the...

Clinical Gastroenterology and Hepatology  Screening for Fibrosis Promotes Lifestyle Changes: A Prospective Cohort Study in 4796 Individuals Volume 22, Issue 5P1037-1047.E9May 2024 This prospective cohort study involving nearly 4,800 individuals investigated whether early detection of liver fibrosis encourages people to make healthier life choices, specifically focusing on those at risk for alcohol...

Clinical Gastroenterology and Hepatology  Defining Small Intestinal Bacterial Overgrowth by Culture and High Throughput Sequencing Volume 22, Issue 2P259-270February 2024

Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022 Volume 166, Issue 4, 605 - 619

Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers  THE NEXT ARTICLE IS FROM JOURNAL Gastroenterology Volume 167, Issue 4 P778-787.E3September 2024

Metabolic Dysfunction–Associated Fibrosis 5 (MAF-5) Score Predicts Liver Fibrosis Risk and Outcome in the General Population With Metabolic Dysfunction   Gastroenterology  Volume 167, Issue 2, 357 - 367.e9

Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial Volume 166, Issue 4, 690 - 703